Colon Neoplasms
19
2
2
11
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.3%
1 terminated out of 19 trials
91.7%
+5.1% vs benchmark
0%
0 trials in Phase 3/4
27%
3 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (19)
Feasibility Study of the SEGER Device in Laparoscopic Gastrointestinal Surgery
A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)
Application of 3D Reconstruction for Preoperative Strategy of Locally Advanced Colon Cancer
Palbociclib and Cetuximab in Metastatic Colorectal Cancer
Comprehensive Analysis of Gut Microbiota Signatures in Metastatic Colorectal Cancer
Sentinel Node and Organ-sparing Surgery in Stage I Colon Carcinoma
Precision of Optical Diagnosis in Polyps Between 5-15 mm and Its Implications on Surveillance. A Prospective, Multicenter Study.
Fluorescent Evaluation of Colorectal Anastamoses
Health and Employment After Gastro Intestinal Surgery - HEAGIS2
Multicenter Single-port Colectomy RCT
AZD6244 With Cetuximab for Solid Tumors and Colorectal Cancer
CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Ultrasound Therapy and Therapeutic Exercise for Chemotherapy Induced Peripheral Neuropathy (CIPN)
Cancer Vaccine Targeting Brachyury Protein in Tumors
A Novel Technique of HALS With CME and CVL for RCC
Backwards Examination of the Right Colon: A Back-to-back Study
Endocuff-assisted vs. Standard Colonoscopy
Full Spectrum vs. Standard Forward-viewing Colonoscopy
The Role of Indocyanine Green (ICG) Fluorescence Imaging on Anastomotic Leak in Robotic Colorectal Surgery